HIV Prevention in Clinical Care Settings: 2014 Recommendations of the International Antiviral Society–USA Panel

作者：N. Kumarasamy, K.H. Mayer, J.S.G. Montaner, J. Sugarman, B. Grinsztejn, Seth C. Kalichman, David R. Holtgräve, Darrell P. Wheeler, Jeanne Marrazzo, Steven Shoptaw, Robert M. Grant, M.S. Cohen, C.A. Benson, C. Del Rio, Rochelle P. Walensky, François Dabis · 发表于：UNC Libraries · 年份：2023 · DOI：10.17615/8d0w-bx53 · 被引用次数：7 · 研究领域：HIV/AIDS Research and Interventions

IMPORTANCE: Emerging data warrant the integration of biomedical and behavioral recommendations for human immunodeficiency virus (HIV) prevention in clinical care settings. OBJECTIVE: To provide current recommendations for the prevention of HIV infection in adults and adolescents for integration in clinical care settings. DATA SOURCES, STUDY SELECTION, AND DATA SYNTHESIS: Data published or presented as abstracts at scientific conferences (past 17 years) were systematically searched and reviewed by the International Antiviral (formerly AIDS) Society-USA HIV Prevention Recommendations Panel. Panel members supplied additional relevant publications, reviewed available data, and formed recommendations by full-panel consensus. RESULTS: Testing for HIV is recommended at least once for all adults and adolescents, with repeated testing for those at increased risk of acquiring HIV. Clinicians should be alert to the possibility of acute HIV infection and promptly pursue diagnostic testing if suspected. At diagnosis of HIV, all individuals should be linked to care for timely initiation of antiretroviral therapy (ART). Support for adherence and retention in care, individualized risk assessment and counseling, assistance with partner notification, and periodic screening for common sexually transmitted infections (STIs) is recommended for HIV-infected individuals as part of care. In HIV-uninfected patients, those persons at high risk of HIV infection should be prioritized for delivery of int...